Fundz

Spectral Medical reported raising $2.67 Million in an initial SEC Form D filing, from an offering of $2.67 Million

PRIVATENov 10, 2022

Amount Raised

$2.67 Million

$2.67 Million sold, per SEC Form D (first sale Oct 28, 2022)

Round Type

Seed

TorontoHealthcare

Quick answer

Spectral Medical raised $2.67 Million in a Seed round, dated October 28, 2022. Spectral Medical is based in Toronto, Ontario, Canada.

How much did Spectral Medical raise?
Spectral Medical raised $2.67 Million in a Seed round on October 28, 2022.
What does Spectral Medical do?
Spectral is a Phase III company seeking U.S. FDA approval for its lead theranostics product for the treatment of endotoxemic septic shock.
Where is Spectral Medical based and how big is it?
Spectral Medical is based in Toronto, Ontario, Canada.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Spectral Medical that raised within 45 days of this round, from Fundz verified event records.

  • PaxeraHealth raised $5.5M on December 12, 2022.
  • Amagma, Inc. raised $10M on December 12, 2022.
  • HistoSonics raised $85M on December 12, 2022.
  • RETINA-AI Health raised $2.6M (Seed) on December 12, 2022.
  • SURGERY CENTERS OF DES MOINES LTD raised $96K (Pre-Seed) on December 12, 2022.
  • Sedalia Retirement raised $4.8M (Seed) on December 9, 2022.

Who to call at Spectral Medical, and when

A new round usually means Spectral Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Spectral Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Spectral Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Spectral Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Spectral Medical

Location

135 THE WEST MALL

Toronto, Ontario, Canada

About

Spectral is a Phase III company seeking U.S. FDA approval for its lead theranostics product for the treatment of endotoxemic septic shock. PMX is a therapeutic hemoperfusion device that removes endotoxin, a main trigger of sepsis, from the bloodstream. Directed by the Company's Endotoxin Activity Assay (EAA™), the only FDA cleared diagnostic for the risk of developing sepsis, Spectral's EUPHRATES trial is the world's only active and most innovative Phase III study in the area of septic shock. PMX has been approved for therapeutic use in Japan and Europe, and has been used safely and effectively on more than 100,000 patients to date. In March 2009, Spectral obtained the exclusive development and commercial rights in the U.S. for PMX, and in November 2010, signed an exclusive distribution agreement for this product in Canada. Approximately 350,000 patients are diagnosed with septic shock in North America each year, representing a greater than $3 billion market opportunity for Spectral. Spectral is listed on the Toronto Stock Exchange currently under the symbol EDT, and on the EDTXF under the symbol EDTXF.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Spectral Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Spectral Medical's next move

See what Strategic adds

Spectral Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.